American Express Company (AXP)
Latest news, insights and market data
Market Data
AI Insights
American Express has been upgraded to Neutral by Redburn after a significant price drop since January, suggesting a more balanced valuation. This shift comes as the company continues to show solid revenue growth, which could help restore investor confidence. Watch for how this upgrade impacts AXP's market perception moving forward.
Latest News
| Title | Published |
|---|---|
The high-end card changes that are challenging banks The high-end card changes that are challenging banks | about 3 hours ago |
The high-end card changes that are challenging banks Increased costs, a limited consumer pool and churn are pressuring the financial institutions that are competing in the luxury card market. | about 3 hours ago |
Visa Stock Offers Growth, but is it Worth Buying at 24.9X Forward P/E? Visa Stock Offers Growth, but is it Worth Buying at 24.9X Forward P/E? | about 4 hours ago |
Visa Stock Offers Growth, but is it Worth Buying at 24.9X Forward P/E? V's premium valuation is backed by strong margins, VAS growth, AI and stablecoin moves, but rising competition and regulation temper near-term upside. | about 4 hours ago |
VIRT or AXP: Which Is the Better Value Stock Right Now? VIRT or AXP: Which Is the Better Value Stock Right Now? | about 5 hours ago |
VIRT or AXP: Which Is the Better Value Stock Right Now? VIRT vs. AXP: Which Stock Is the Better Value Option? | about 5 hours ago |
Armata Pharmaceuticals Shares Rise 8% After FDA Grants AP-SA02 Breakthrough Therapy Designation Armata Pharmaceuticals Shares Rise 8% After FDA Grants AP-SA02 Breakthrough Therapy Designation | about 7 hours ago |
The high-end card changes that are challenging banks
The high-end card changes that are challenging banks
The high-end card changes that are challenging banks
Increased costs, a limited consumer pool and churn are pressuring the financial institutions that are competing in the luxury card market.
Visa Stock Offers Growth, but is it Worth Buying at 24.9X Forward P/E?
Visa Stock Offers Growth, but is it Worth Buying at 24.9X Forward P/E?
Visa Stock Offers Growth, but is it Worth Buying at 24.9X Forward P/E?
V's premium valuation is backed by strong margins, VAS growth, AI and stablecoin moves, but rising competition and regulation temper near-term upside.
VIRT or AXP: Which Is the Better Value Stock Right Now?
VIRT or AXP: Which Is the Better Value Stock Right Now?
VIRT or AXP: Which Is the Better Value Stock Right Now?
VIRT vs. AXP: Which Stock Is the Better Value Option?
Armata Pharmaceuticals Shares Rise 8% After FDA Grants AP-SA02 Breakthrough Therapy Designation
Armata Pharmaceuticals Shares Rise 8% After FDA Grants AP-SA02 Breakthrough Therapy Designation